Webhealth Logo

A Network Connecting Healthcare Professionals
WebHealthNetwork Membership: 2,370,806

EN / ES

sign up

log in

Sign Up On Webhealth Network

Sign Up On Jobs At Webhealth Network

LogIn On Webhealth Network

LogIn On Jobs At Webhealth Network

Webhealth Logo
  • Home
  • HealthCare Directory
    • US Medical Doctor Directory
    • US Nurse Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Research Articles
  • Videos
  • Solutions
  • Jobs
    • Search For Jobs Post A Job
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Acute Leukemia of Ambiguous Lineage - 33 Studies Found

Status Study
Recruiting Study Name: Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Condition: de Novo Myelodysplastic Syndrome Mixed Phenotype Acute Leukemia
Date: 2016-09-29
Interventions: Drug: Cladribine Given IV
Recruiting Study Name: Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
Condition: B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR
Date: 2016-08-23
Interventions: Biological: Blinatumomab Given
Recruiting Study Name: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Condition: Acute Leukemia of Ambiguous Lineage Childhood B Acute Lymphobla
Date: 2016-07-07
Interventions: Drug: Azacitidine Given IV
Recruiting Study Name: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
Condition: Leukemia, Acute Lymphoblastic Acute Myeloid Leukemia
Date: 2016-06-09
Interventions: Procedure: Allogeneic stem cell transplantation
Recruiting Study Name: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Condition: Myelodysplastic Syndrome (MDS) Chronic Lymphocytic Leukemia (CLL)
Date: 2016-05-31
Interventions: Drug: Fludarabine
Not yet recruiting Study Name: Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Condition: Hematologic Malignancy
Date: 2016-03-16
Interventions: Drug: Fludarabine
Recruiting Study Name: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Condition: Acute Biphenotypic Leukemia Acute Myeloid Leukemia
Date: 2016-03-14
Interventions: Drug: Cladribine Given IV
Not yet recruiting Study Name: Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Condition: Acute Lymphoblastic Leukemia in Complete Remission Lymphoblastic Lymphoma in Complete Remiss
Date: 2015-09-30
Interventions: Drug: Ixazomib Patients who have been on stable doses of 6 - MP, vincristine, and methotrexate for a min
Recruiting Study Name: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Condition: Acute Leukemia of Ambiguous Lineage Recurrent Adult Acute Lymph
Date: 2015-08-25
Interventions: Other: Chemosensitivity Assay
Terminated Study Name: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Condition: Mixed Lineage Acute Leukemia Acute Myeloid Leukemia
Date: 2015-04-14
Interventions: Drug: Bortezomib Bortezomib wi
Page 1 of 4
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy
  • Sitemap

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.